A Randomized Controlled Trial of Intravenous N-acetylcysteine in the Management of Anti-tuberculosis Drug-Induced Liver Injury

Clicks: 150
ID: 112020
AbstractBackground. Liver injury is a common complication of first-line anti-tuberculosis therapy. N-acetylcysteine (NAC) is widely used in patients with parac
Reference Key
sclinicala Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Moosa, Muhammed S;Maartens, Gary;Gunter, Hannah;Allie, Shaazia;Chughlay, Mohamed F;Setshedi, Mashiko;Wasserman, Sean;Hickman, Nicole;Stewart, Annemie;Sonderup, Mark;Spearman, Catherine Wendy;Cohen, Karen;
Journal clinical infectious diseases
Year Year not found
DOI DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.